These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 15037716)

  • 1. Periodic paralysis mutation MiRP2-R83H in controls: Interpretations and general recommendation.
    Jurkat-Rott K; Lehmann-Horn F
    Neurology; 2004 Mar; 62(6):1012-5. PubMed ID: 15037716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of association of the potassium channel-associated peptide MiRP2-R83H variant with periodic paralysis.
    Sternberg D; Tabti N; Fournier E; Hainque B; Fontaine B
    Neurology; 2003 Sep; 61(6):857-9. PubMed ID: 14504341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mutation in the KCNE3 potassium channel gene is associated with susceptibility to thyrotoxic hypokalemic periodic paralysis.
    Dias Da Silva MR; Cerutti JM; Arnaldi LA; Maciel RM
    J Clin Endocrinol Metab; 2002 Nov; 87(11):4881-4. PubMed ID: 12414843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlating phenotype and genotype in the periodic paralyses.
    Miller TM; Dias da Silva MR; Miller HA; Kwiecinski H; Mendell JR; Tawil R; McManis P; Griggs RC; Angelini C; Servidei S; Petajan J; Dalakas MC; Ranum LP; Fu YH; Ptácek LJ
    Neurology; 2004 Nov; 63(9):1647-55. PubMed ID: 15534250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiRP2 forms potassium channels in skeletal muscle with Kv3.4 and is associated with periodic paralysis.
    Abbott GW; Butler MH; Bendahhou S; Dalakas MC; Ptacek LJ; Goldstein SA
    Cell; 2001 Jan; 104(2):217-31. PubMed ID: 11207363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No mutation in the KCNE3 potassium channel gene in Chinese thyrotoxic hypokalaemic periodic paralysis patients.
    Tang NL; Chow CC; Ko GT; Tai MH; Kwok R; Yao XQ; Cockram CS
    Clin Endocrinol (Oxf); 2004 Jul; 61(1):109-12. PubMed ID: 15212652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorylation and protonation of neighboring MiRP2 sites: function and pathophysiology of MiRP2-Kv3.4 potassium channels in periodic paralysis.
    Abbott GW; Butler MH; Goldstein SA
    FASEB J; 2006 Feb; 20(2):293-301. PubMed ID: 16449802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genotype-phenotype correlation and therapeutic rationale in hyperkalemic periodic paralysis.
    Jurkat-Rott K; Lehmann-Horn F
    Neurotherapeutics; 2007 Apr; 4(2):216-24. PubMed ID: 17395131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muscle channelopathies.
    Saperstein DS
    Semin Neurol; 2008 Apr; 28(2):260-9. PubMed ID: 18351527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical and molecular genetic analysis of a family with normokalemic periodic paralysis].
    Wei CJ; Wang D; Wang S; Jiao H; Hong DJ; Pu LH; Xiong H
    Zhonghua Er Ke Za Zhi; 2013 Jan; 51(1):47-51. PubMed ID: 23527931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary periodic paralyses.
    Finsterer J
    Acta Neurol Scand; 2008 Mar; 117(3):145-58. PubMed ID: 18031562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Periodic paralysis.
    Fontaine B
    Adv Genet; 2008; 63():3-23. PubMed ID: 19185183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperkalemic periodic paralysis and paramyotonia congenita--a novel sodium channel mutation.
    Okuda S; Kanda F; Nishimoto K; Sasaki R; Chihara K
    J Neurol; 2001 Nov; 248(11):1003-4. PubMed ID: 11757950
    [No Abstract]   [Full Text] [Related]  

  • 14. [Neuromuscular hereditary channelopathies: non-dystrophic myotonias, paramyotonias and periodic paralysis].
    Ruggieri VL; Arberas CL
    Rev Neurol; 2002 Jan 16-31; 34(2):150-6. PubMed ID: 11988910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New mutations of SCN4A cause a potassium-sensitive normokalemic periodic paralysis.
    Vicart S; Sternberg D; Fournier E; Ochsner F; Laforet P; Kuntzer T; Eymard B; Hainque B; Fontaine B
    Neurology; 2004 Dec; 63(11):2120-7. PubMed ID: 15596759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of novel single nucleotide polymorphisms in the calcium channel alpha 1 subunit gene (Ca(v)1.1) and thyrotoxic periodic paralysis.
    Kung AW; Lau KS; Fong GC; Chan V
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1340-5. PubMed ID: 15001631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient page. Attacks of immobility caused by diet or exercise? The mystery of periodic paralyses.
    Levitt J; Cochran P; Jankowiak J
    Neurology; 2004 Nov; 63(9):E17-8. PubMed ID: 15534231
    [No Abstract]   [Full Text] [Related]  

  • 18. An expanding view for the molecular basis of familial periodic paralysis.
    Cannon SC
    Neuromuscul Disord; 2002 Aug; 12(6):533-43. PubMed ID: 12117476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe infantile hyperkalaemic periodic paralysis and paramyotonia congenita: broadening the clinical spectrum associated with the T704M mutation in SCN4A.
    Brancati F; Valente EM; Davies NP; Sarkozy A; Sweeney MG; LoMonaco M; Pizzuti A; Hanna MG; Dallapiccola B
    J Neurol Neurosurg Psychiatry; 2003 Sep; 74(9):1339-41. PubMed ID: 12933953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normokalemic periodic paralysis revisited: does it exist?
    Chinnery PF; Walls TJ; Hanna MG; Bates D; Fawcett PR
    Ann Neurol; 2002 Aug; 52(2):251-2. PubMed ID: 12210802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.